154 related articles for article (PubMed ID: 21669453)
1. Genotype-independent in vivo oxidative stress following a methionine loading test: maximal platelet activation in subjects with early-onset thrombosis.
Di Minno MN; Pezzullo S; Palmieri V; Coppola A; D'Angelo A; Sampietro F; Cavalca V; Tremoli E; Di Minno G
Thromb Res; 2011 Oct; 128(4):e43-8. PubMed ID: 21669453
[TBL] [Abstract][Full Text] [Related]
2. Oxidative stress and platelet activation in subjects with moderate hyperhomocysteinaemia due to MTHFR 677 C→T polymorphism.
Dragani A; Falco A; Santilli F; Basili S; Rolandi G; Cerasa L; Lattanzio S; Ciabattoni G; Patrono C; Davì G
Thromb Haemost; 2012 Sep; 108(3):533-42. PubMed ID: 22782530
[TBL] [Abstract][Full Text] [Related]
3. Oxidative stress and platelet activation in homozygous homocystinuria.
Davì G; Di Minno G; Coppola A; Andria G; Cerbone AM; Madonna P; Tufano A; Falco A; Marchesani P; Ciabattoni G; Patrono C
Circulation; 2001 Sep; 104(10):1124-8. PubMed ID: 11535567
[TBL] [Abstract][Full Text] [Related]
4. Inflammation, oxidative stress and platelet activation in aspirin-treated critical limb ischaemia: beneficial effects of iloprost.
Lessiani G; Vazzana N; Cuccurullo C; Di Michele D; Laurora G; Sgrò G; Di Ruscio P; Simeone E; Di Iorio P; Lattanzio S; Liani R; Ferrante E; Davì G
Thromb Haemost; 2011 Feb; 105(2):321-8. PubMed ID: 21103664
[TBL] [Abstract][Full Text] [Related]
5. Contribution of the cystathionine beta-synthase gene (844ins68) polymorphism to the risk of early-onset venous and arterial occlusive disease and of fasting hyperhomocysteinemia.
de Franchis R; Fermo I; Mazzola G; Sebastio G; Di Minno G; Coppola A; Andria G; D'Angelo A
Thromb Haemost; 2000 Oct; 84(4):576-82. PubMed ID: 11057853
[TBL] [Abstract][Full Text] [Related]
6. Hyperhomocysteinemia: could the post-methionine oral loading test sometimes be avoided?
Marongiu F; Fenu L; Pisu G; Contu P; Barcellona D
Haematologica; 2003 Feb; 88(2):186-91. PubMed ID: 12604408
[TBL] [Abstract][Full Text] [Related]
7. Reduced in vivo oxidative stress following 5-methyltetrahydrofolate supplementation in patients with early-onset thrombosis and 677TT methylenetetrahydrofolate reductase genotype.
Coppola A; D'Angelo A; Fermo I; Mazzola G; Di Minno MN; Cajani A; Sala A; Folco G; Tremoli E; Di Minno G
Br J Haematol; 2005 Oct; 131(1):100-8. PubMed ID: 16173969
[TBL] [Abstract][Full Text] [Related]
8. Plasma homocysteine after insulin infusion in type II diabetic patients with and without methionine intolerance.
Ventura P; Panini R; Emiliani S; Salvioli G
Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):44-51. PubMed ID: 14758571
[TBL] [Abstract][Full Text] [Related]
9. Determinants of thromboxane biosynthesis in rheumatoid arthritis: Role of RAGE and oxidant stress.
Ferrante E; Vazzana N; Santilli F; Di Cicco M; Lauriti C; Di Battista L; Ciabattoni G; Di Matteo L; Davì G
Free Radic Biol Med; 2010 Sep; 49(5):857-64. PubMed ID: 20541603
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous quantification of 8-iso-prostaglandin-F(2alpha) and 11-dehydro thromboxane B(2) in human urine by liquid chromatography-tandem mass spectrometry.
Cavalca V; Minardi F; Scurati S; Guidugli F; Squellerio I; Veglia F; Dainese L; Guarino A; Tremoli E; Caruso D
Anal Biochem; 2010 Feb; 397(2):168-74. PubMed ID: 19825360
[TBL] [Abstract][Full Text] [Related]
11. Endogenous secretory RAGE in obese women: association with platelet activation and oxidative stress.
Vazzana N; Guagnano MT; Cuccurullo C; Ferrante E; Lattanzio S; Liani R; Romano M; Davì G
J Clin Endocrinol Metab; 2012 Sep; 97(9):E1726-30. PubMed ID: 22761461
[TBL] [Abstract][Full Text] [Related]
12. [The abnormal reaction to post methionine loading test in type diabetes with or without retinopathy].
Guo Q; Lu J; Pan C
Zhonghua Yi Xue Za Zhi; 2002 Jun; 82(11):725-8. PubMed ID: 12126538
[TBL] [Abstract][Full Text] [Related]
13. Determinants of platelet activation in Alzheimer's disease.
Ciabattoni G; Porreca E; Di Febbo C; Di Iorio A; Paganelli R; Bucciarelli T; Pescara L; Del Re L; Giusti C; Falco A; Sau A; Patrono C; Davì G
Neurobiol Aging; 2007 Mar; 28(3):336-42. PubMed ID: 16442186
[TBL] [Abstract][Full Text] [Related]
14. Intermediate and severe hyperhomocysteinemia with thrombosis: a study of genetic determinants.
Gaustadnes M; Rüdiger N; Rasmussen K; Ingerslev J
Thromb Haemost; 2000 Apr; 83(4):554-8. PubMed ID: 10780316
[TBL] [Abstract][Full Text] [Related]
15. [Effect of polymorphisms on key enzymes in homocysteine metabolism, on plasma homocysteine level and on coronary artery-disease risk in a Tunisian population].
Belkahla R; Omezzine A; Kchok K; Rebhi L; Ben Hadj Mbarek I; Rejeb J; Ben Rejeb N; Slimane N; Nabli N; Ben Abdelaziz A; Boughzala E; Bouslama A
Ann Cardiol Angeiol (Paris); 2008 Aug; 57(4):219-24. PubMed ID: 18620331
[TBL] [Abstract][Full Text] [Related]
16. The C677T mutation in methylenetetrahydrofolate reductase gene, plasma homocysteine concentration and the risk of coronary artery disease.
Kadziela J; Janas J; Dzielińska Z; Szperl M; Gaździk D; Chotkowska E; Piotrowski W; Ruzyłło W
Kardiol Pol; 2003 Jul; 59(7):17-26; discussion 26. PubMed ID: 14560345
[TBL] [Abstract][Full Text] [Related]
17. Effects of vitamin E supplementation on F(2)-isoprostane and thromboxane biosynthesis in healthy cigarette smokers.
Patrignani P; Panara MR; Tacconelli S; Seta F; Bucciarelli T; Ciabattoni G; Alessandrini P; Mezzetti A; Santini G; Sciulli MG; Cipollone F; Davì G; Gallina P; Bon GB; Patrono C
Circulation; 2000 Aug; 102(5):539-45. PubMed ID: 10920066
[TBL] [Abstract][Full Text] [Related]
18. Methylenetetrahydrofolate reductase (MTHFR-677 and MTHFR-1298) genotypes and haplotypes and plasma homocysteine levels in patients with occlusive artery disease and deep venous thrombosis.
Spiroski I; Kedev S; Antov S; Arsov T; Krstevska M; Dzhekova-Stojkova S; Bosilkova G; Kostovska S; Trajkov D; Petlichkovski A; Strezova A; Efinska-Mladenovska O; Spiroski M
Acta Biochim Pol; 2008; 55(3):587-94. PubMed ID: 18800176
[TBL] [Abstract][Full Text] [Related]
19. Plasma homocysteine levels, methylene tetrahydrofolate reductase A1298C gene polymorphism and risk of retinal vein thrombosis.
Ghaznavi H; Soheili Z; Samiei S; Soltanpour MS
Blood Coagul Fibrinolysis; 2016 Sep; 27(6):679-83. PubMed ID: 26650461
[TBL] [Abstract][Full Text] [Related]
20. Determinants of thromboxane biosynthesis in patients with moderate to severe chronic kidney disease.
Vazzana N; Santilli F; Lattanzio S; Liani M; Giacci L; Del Rosso G; Salvati F; Boccatonda A; Ferroni P; Davì G
Eur J Intern Med; 2016 Sep; 33():74-80. PubMed ID: 27389698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
